respiratory

Professor Emad El-Omar on why harnessing the microbiome isn’t sci-fi

The microbiome has been hailed as the “new frontier” in medicine. In this week’s Holy Grail, Professor Emad El-Omar, director of the new Microbiome Research Centre based at St George’s Hospital and University of NSW in Sydney, predicts where the...

The microbiome has been hailed as the “new frontier” in medicine. In this week’s Holy Grail, Professor Emad El-Omar, director...

Read more
Medical politics

Bid to stop “dangerous” CAM scenario becoming a reality

Consumer advocates have made an 11th hour bid to force manufacturers to declare when therapeutic claims for their complementary medicines are based solely on traditional use. The TGA has now approved its list of “permitted indications” for therapeutic goods, which includes...

Consumer advocates have made an 11th hour bid to force manufacturers to declare when therapeutic claims for their complementary medicines...
ILD

IPF can learn lessons from oncology

Genetic testing in idiopathic pulmonary fibrosis (IPF) can help patients now - even without the targeted medicines that will inevitably become available, according to an expert in telomere-mediated disease. Dr Mary Armanios, Professor of Oncology at John Hopkins Medicine, told the...

Genetic testing in idiopathic pulmonary fibrosis (IPF) can help patients now - even without the targeted medicines that will inevitably...
Lifestyle

Burnout requires systemic change

Well-meant resilience training for junior doctors won’t make a scrap of difference to the epidemic of burnout in the medical profession without systemic changes. Dr Tait Shanafelt, a haematologist/oncologist who is also Chief Wellness Officer at Stanford Medicine, told ATS 2018...

Well-meant resilience training for junior doctors won’t make a scrap of difference to the epidemic of burnout in the medical...